ArticleProceedings of the National Academy of Sciences of the United States of America2006

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Christine Beeton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.